Specialty pharmaceutical company Avion Pharmaceuticals has launched a prescription prenatal supplement with B vitamins and Ginger, Prenate AM, to ease pregnancy symptoms like nausea and vomiting in pregnancy (NVP). Avion CEO Mark Pugh ...
Tags: Prenatal Supplement, Medicine
La Jolla Pharmaceutical Company has reported a comprehensive net loss attributable to common stockholders of $3.74m, or $0.14 per share, for the second quarter ended on 30 June 2013 compared with $7.77m, or $0.67 per share in 2012. ...
Tags: La Jolla Pharmaceutical, Net Loss
Clinical-stage pharmaceutical company Adynxx has obtained the US Food and Drug Administration (FDA) fast track designation for its AYX1 injection, which is used for prevention of chronic pain. In a five-cohort, dose-escalating study ...
Specialty pharmaceutical company Iroko Pharmaceuticals has announced the FDA acceptance for New Drug Application (NDA) filing of lower dose submicron Indomethacin, a non-steroidal anti-inflammatory drug. The proposed indication of the ...
Tags: FDA Acceptance, NDA Filing
Mylan Pharmaceuticals has introduced Norethindrone Tablets USP, 0.35mg, which is the generic version of Watson Laboratories' (now Actavis) Nor-Q.D. tablets, 0.35mg for 28-day cycle, for the prevention of pregnancy in the US. The ...
Tags: Generic Contraceptive Pill, Mylan
Indian based pharmaceutical company Cipla has completed the acquisition of Cipla Medpro South Africa for a consideration of ZAR4.507bn ($456.43m). Commenting on the development Cipla managing director and global CEO Subhanu Saxena was ...
Tags: Cipla, Cipla Medpro
Qumas, a provider of enterprise compliance technologies, has signed a contract to supply an integrated compliance platform to a Swiss pharmaceutical company for regulatory submissions and quality management. The company leverages the ...
Tags: Qumas, Pharmaceutical Company
Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
Specialty pharmaceutical company Actavis has won FDA approval for abbreviated new drug application (ANDA) of generic equivalent to Endo Health Solutions' Opana ER. Oxymorphone Hydrochloride extended-release tablets, which is available in ...
Tags: FDA, ANDA, Generic Opana ER
Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...
Tags: Tris Pharma, Medicine
Accenture has launched a new business service, known as Accelerated R&D Services, to accelerate drug development from discovery to approval to market. Focused on delivering streamlined and integrated research and development (R&D) ...
Tags: Drugs, R&D Service
Cegedim Relationship Management has revealed that an undisclosed Spain-based international pharmaceutical company has deployed Cloud-Based Mobile Intelligence CRM for Tablets and PCs for their Primary and Specialty sales forces in the ...
Tags: Pharma Company, CRM Solution
Generic and specialty pharmaceutical company Mylan Pharmaceuticals has introduced a portfolio of women's healthcare products in India, expanding its product base in the country. Consisting of eight products initially, the portfolio is ...
Tags: Women's Care Products, Medicine
Global pharmaceutical company Eisai has rolled out Aricept Dry Syrup 1%, a new medicine for Alzheimer's disease treatment Aricept (donepezil hydrochloride) in Japan. The formulation received Japan manufacturing and marketing authorization ...
Tags: Eisai, Disease Treatment
Pharmaceutical company Pendopharm, in consultation with Health Canada, has announced the voluntary recall of two lots of the ACET-650 acetaminophen suppository (DIN 02230437) due to dosage mislabeling on the blister packs inside the box. ...